Showing results (181-190 of 3,343) with videos related to
Sort By:
Pageof 335
Plos One|March 22, 2013
Isolation of rare tumor cells from blood cells with buoyant immuno-microbubblesGuixin Shi, Wenjin Cui, Michael Benchimol, et al.Oncotarget|November 16, 2020
Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesisMyoung Sook Kim, Ramkishore Gernapudi, Yessenia Cedeño Cedeño, et al.Future Science OA|April 24, 2023
Exploring the role of cerebrospinal fluid as analyte in neurologic disordersSandeep C Pingle, Feng Lin, Misa S Anekoji, et al.Journal of Neuro-Oncology|December 7, 2010
Longitudinal MRI evidence for decreased survival among periventricular glioblastomaGeoffrey S Young, Eric A Macklin, Kian Setayesh, et al.Bioconjugate Chemistry|April 21, 2012
Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domainsYing Chao, Milan Makale, Priya Prakash Karmali, et al.Cancer Cell International|June 2, 2009
Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid beta proteinHong Zhao, Jinmin Zhu, Kemi Cui, et al.Neuro-Oncology|April 1, 2009
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumabEudocia C Quant, Andrew D Norden, Jan Drappatz, et al.Cureus|November 18, 2022
Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative DiseasesJesus A Perez, Javier J Lopez, Claudia C Torres Badillo, et al.Cell Cycle (Georgetown, Tex.)|February 20, 2015
Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristicsShumei Kato, Maria Schwaederle, Gregory A Daniels, et al.Cureus|November 16, 2022
Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative DiseasesJesus A Perez, Javier J Lopez, Claudia C Torres Badillo, et al.Pageof 335